Amanta Healthcare Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementCfo Debt Reduction RoadmapAnalyst Day Multiyear TargetsInvestor Communications View source PDF

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.7%1-day move

₹132.00

prior close

₹131.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.9-1.5-2.3-4.7-1.5-0.8+1.3+0.2-8.3+12.6+21.6+24.7—

Up moveDown movePending

AI summary

Amanta Healthcare reported FY26 revenue of ₹288 Cr (up 5% YoY) and PAT of ₹15 Cr (up 42% YoY), with EBITDA margins improving to 22%. Q4FY26 showed revenue of ₹77 Cr (up 7% YoY) and PAT of ₹5.5 Cr (up 28% YoY). The company has significantly deleveraged with Debt-to-Equity improving from 3.50x in FY23 to 1.06x in FY26, repaying over ₹30 Cr of borrowings. Management targets 20%+ revenue CAGR and 25%+ EBITDA margins for the next two years, driven by capacity expansion (SteriPort from 6.6 Cr to 11.6 Cr bottles and SVP from 20.9 Cr to 31.7 Cr units by FY27) and a 10.8 MW solar plant expected to save ₹9 Cr annually.

Likely market impact

Strong profitability growth and aggressive debt reduction signal improving financial health and shareholder value creation. The capacity expansion targeting ₹110-120 Cr incremental revenue could drive re-rating if executed as guided.